Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (6): 954-960. doi: 10.3969/j.issn.1671-167X.2017.06.004

• Article • Previous Articles     Next Articles

Effect of high glucose-based peritoneal dialysis fluids on NLRP3-IL-1β in human peritoneal mesothelial cells#br#

LI Xiang-you, WU Jun△, LUO Dan, CHEN Wan-xian, ZHU Ge-li, ZHANG Yan-xia, BI Zhi-min, FENG Bao-hong   

  1. (Department of Nephrology,Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan 430068, China)
  • Online:2017-12-18 Published:2017-12-18
  • Contact: WU Jun E-mail: wujun2@mail3.sysu.edu.cn
  • Supported by:
    Supported by National Natural Science Foundation of China (81200555), Natural Science Foundation of Hubei Province (2016CFB590), and Project of Health and Fa-mily Planning Commission of Wuhan Municipality (WX16B09)

Abstract: Objective: To explore the effect of high glucose-based peritoneal dialysis fluids on NLRP3-IL-1β in human peritoneal mesothelial cells. Methods: HMrSV5 cells (SV40 immortalized human peritoneal mesothelial cell line) were grown in type Ⅰ collagen-coated dishes in DMEM/F12 containing 10% fetal calf serum (FCS). All experiments on HMrSV5 cells were performed between passages 5 and 10-The cells were divided into 7 groups: control, 1-5% dextrose, 2-5% dextrose, 425% dextrose, rotenone, thenoyltrifluoroacetone (TTFA), and antimycin A-Immunoblotting was used to evaluate the expression of IL-1β-Small interfering RNA (siRNA) targeting NLRP3 was used to downregulate the expression of NLRP3 and Western blot was used to evaluate the expression of IL-1β in human peritoneal mesothelial cells exposed to 4-25% dextrose- In the meanwhile, resveratrol (RSV) was used to induce autophagy, 3-methyladenine (3-MA) and siRNA against Beclin 1 or ATG5 were used to block auto-phagy, flow cytometric was used to analyze the respiring (mitotracker deep red), total (mitotracker green) and reactive oxygen species (ROS)generating mitochondria (mitoSOX); Western blot was used to evaluate the expression of IL-1β- Results: The IL-1β relative expressions were 0, 0-175±0-082, 0-418±0-163, 2-357±0-288, 2-642±0-358, 3-271±0-462, and 0-123±0-091, indicating that the cells exposed to high glucose-based peritoneal dialysis fluids and cells treated with mitochondria respiratory chain key enzyme complex Ⅰ, and complex Ⅲ inhibitors increased the IL-1β expression- And we found that NLRP3 knock-down significantly blocked the upregulation of IL-1β- In addition, the fluorescence intensity of total mitochondria and ROS-generating mitochondria in the following groups: control, negative control, RSV, 3-MA, ATG5 siRNA, Beclin1 siRNA were 1-76±0-42, 1-83±0-55, 1-85±0-62, 7-36±0-92, 5-35±0-77, 5-06±0-62 and 821-68±95-12, 868-15±102-82, 723-39±92-56, 1 660-08±113-65, 1 433-01±107-24, 1 562-36±112-88 respectively- The increased concentrations of mitochondrial ROS and IL-1β upregulation were confirmed in the inhibition but not the induction of auto-phagy-We also found that downregulation of ATG5 and Beclin1 sensitized cells for the release of IL-1β induced by MSU (monosodium urate) or nigericin which was the NLRP3 inflammasome activator- RSV treatment attentuated this effect- Conclusion: Long-term application of high glucose-based peritoneal dialysis fluids can trigger the consistent activation of NLRP3-IL-1β in peritoneal mesothelial cells-Timely initiation of autophagy may block the NLRP3-IL-1β activation and provide a basis for the further development of a potential therapeutic strategy for delay of chronic inflammation and peritoneal fibrosis associated with peritoneal dialysis.

Key words: High glucose-based peritoneal dialysis fluids, Human peritoneal mesothelial cells, NLRP3, IL-1β

CLC Number: 

  • R692
[1] Qiming ZHANG, Zebo CHEN, Yu TIAN, Dameng PAN, Lei LIU, Hongxian ZHANG, Lei ZHAO, Shudong ZHANG, Lulin MA, Xiaofei HOU. Experience summary of robot-assisted laparoscopic transplant nephrectomy [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 666-669.
[2] 徐啸, 王海东, 刘振华, 夏海缀. [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 812-816.
[3] Mingrui WANG, Jinhui LAI, Jiaxiang JI, Xinwei TANG, Haopu HU, Qi WANG, Kexin XU, Tao XU, Hao HU. Risk factors for decreased quality of life in patients with kidney stones predicted by the Chinese version of Wisconsin stone quality of life questionnaire [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1069-1074.
[4] Handong DING, Qin WANG, Guiyi LIAO, Zongyao HAO. Diagnosis and treatment of gastrointestinal bleeding after kidney transplantation [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 902-907.
[5] Silu CHEN, Haiju WANG, Yucai WU, Zhihua LI, Yanbo HUANG, Yuhui HE, Yangyang XU, Xuesong LI, Hua GUAN. Etiological analysis of hydronephrosis in adults: A single-center cross-sectional study [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 913-918.
[6] Mingrui WANG, Qi WANG, Hao HU, Jinhui LAI, Xinwei TANG, Chunyan WAN, Kexin XU, Tao XU. Efficacy of coated metal ureteral stent in the treatment of pelvic lipomatosis induced hydronephrosis [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 919-922.
[7] Shengqi ZHENG,Tianchi HUA,Guicao YIN,Wei ZHANG,Ye YAO,Yifan LI. Association between the triglyceride-glucose index and the incidence of nephrolithiasis in male individuals [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 610-616.
[8] Mingrui WANG,Jun LIU,Liulin XIONG,Luping YU,Hao HU,Kexin XU,Tao XU. Efficacy and safety of mini-track, mini-nephroscopy and mini-ultrasonic probe percutaneous nephrolithotomy for the treatment of 1.5-2.5 cm kidney stones [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 605-609.
[9] Ming-rui WANG,Jia-xiang JI,Jin-hui LAI,Xin-wei TANG,Hao-pu HU,Qi WANG,Ke-xin XU,Tao XU,Hao HU. Choice of medical treatment for renal colic: A survey of Chinese urologists [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 871-875.
[10] Wen-han BAO,Wen TANG. Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 124-132.
[11] Zi WANG,Jun-jun ZHANG,Li ZUO,Yue WANG,Wen-ge LI,Hong CHENG,Guang-yan CAI,Hua-ying PEI,Li-hua WANG,Xu-jie ZHOU,Su-fang SHI,Li-jun LIU,Ji-cheng LV,Hong ZHANG. Efficacy of plasma exchange in severe crescentic IgA nephropathy: A multicentered, cohort study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1038-1046.
[12] Lin MA,Jing-yi WU,Shuang-cheng LI,Peng-fei LI,Lu-xia ZHANG. Effect of modification of antihypertensive medications on the association of nitrogen dioxide long-term exposure and chronic kidney disease [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1047-1055.
[13] Ling-yi XU,Miao HUI,Shu-hong ZHU,Zhao YANG,Meng-rui LI,Hong-yu YANG,Xi-zi ZHENG,Ji-cheng LV,Li YANG. Chronic kidney disease in community: Current state for screening and management [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1056-封三.
[14] DAI Xiang,ZUO Mei-ni,ZHANG Xiao-peng,HU Hao,XU Tao. Comparison of long-term outcomes in different managements of diverticular neck in percutaneous nephrolithotomy for diverticular calculi [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 704-709.
[15] QIU Min,WANG Lu,DENG Shao-hui,TA Peng-fei,GUO Wei,LU Jian,LIU Cheng,MA Lu-lin. Primary application of Gerota’s fascia suspension device in retroperitoneal laparoscopic partial nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 789-792.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!